Neuropsychopharmacol Rep. 2024; 45(1):e12497.
PMID: 39587785
PMC: 11666347.
DOI: 10.1002/npr2.12497.
Yoshioka D, Yamanashi T, Iwata M
PCN Rep. 2024; 2(1):e71.
PMID: 38868408
PMC: 11114423.
DOI: 10.1002/pcn5.71.
Chou P, Lee Y, Chang Y, Lin P, Wang L
Clin Psychopharmacol Neurosci. 2023; 21(3):488-498.
PMID: 37424417
PMC: 10335907.
DOI: 10.9758/cpn.22.1000.
Kayastha J, Shrestha R, Shrestha B, Gurung P, Dabadi S, Dhungel R
Ann Med Surg (Lond). 2023; 85(5):1839-1842.
PMID: 37228997
PMC: 10205201.
DOI: 10.1097/MS9.0000000000000126.
Willems A, Mentzel C, Bakker P, van Os J, Tenback D, Gelan P
Schizophr Bull. 2022; 48(4):766-773.
PMID: 35486807
PMC: 9212096.
DOI: 10.1093/schbul/sbac037.
Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".
Neuropsychopharmacol Rep. 2021; 41(3):266-324.
PMID: 34390232
PMC: 8411321.
DOI: 10.1002/npr2.12193.
Prevalence and incidence of oromandibular dystonia: an oral and maxillofacial surgery service-based study.
Yoshida K
Clin Oral Investig. 2021; 25(10):5755-5764.
PMID: 33956216
DOI: 10.1007/s00784-021-03878-9.
Exploring the Relationship Between Movement Disorders and Physical Activity in Patients With Schizophrenia: An Actigraphy Study.
Pieters L, Deenik J, Tenback D, van Oort J, van Harten P
Schizophr Bull. 2021; 47(4):906-914.
PMID: 33764476
PMC: 8266591.
DOI: 10.1093/schbul/sbab028.
Prescription of Anticholinergics in Tardive Syndromes: A "Dual Center" Survey among Psychiatrists.
Cutino A, Bhidayasiri R, Colosimo C
Parkinsons Dis. 2020; 2020:8870945.
PMID: 33299541
PMC: 7704191.
DOI: 10.1155/2020/8870945.
Prevalence of Extrapyramidal Symptoms in In-Patients With Severe Mental Illnesses: Focus on Parkinsonism.
Roiter B, Pigato G, Antonini A
Front Neurol. 2020; 11:593143.
PMID: 33244310
PMC: 7683803.
DOI: 10.3389/fneur.2020.593143.
Drug-Induced Movement Disorders and Its Associated Factors Among Patients Attending Treatment at Public Hospitals in Eastern Ethiopia.
Misgana T, Yigzaw N, Asfaw G
Neuropsychiatr Dis Treat. 2020; 16:1987-1995.
PMID: 32884274
PMC: 7443022.
DOI: 10.2147/NDT.S261272.
Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia.
Caroff S, Mu F, Ayyagari R, Schilling T, Abler V, Carroll B
BMC Psychiatry. 2020; 20(1):365.
PMID: 32652964
PMC: 7353680.
DOI: 10.1186/s12888-020-02748-0.
Proxy WHO Disability Assessment Schedule 2.0 Is Clinically Useful for Assessing Psychosocial Functioning in Severe Mental Illness.
Koopmans A, van Hoeken D, Clarke D, Vinkers D, van Harten P, Hoek H
Front Psychiatry. 2020; 11:303.
PMID: 32351419
PMC: 7174765.
DOI: 10.3389/fpsyt.2020.00303.
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
Begemann M, Thompson I, Veling W, Gangadin S, Geraets C, van t Hag E
Trials. 2020; 21(1):147.
PMID: 32033579
PMC: 7006112.
DOI: 10.1186/s13063-019-3822-5.
The genetics of drug-related movement disorders, an umbrella review of meta-analyses.
van der Burg N, Al Hadithy A, van Harten P, van Os J, Bakker P
Mol Psychiatry. 2020; 25(10):2237-2250.
PMID: 32020047
DOI: 10.1038/s41380-020-0660-5.
[Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 3 : Tardive dyskinesia].
Hirjak D, Kubera K, Bienentreu S, Thomann P, Wolf R
Nervenarzt. 2018; 90(5):472-484.
PMID: 30341543
DOI: 10.1007/s00115-018-0629-7.
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management.
Ward K, Citrome L
Neurol Ther. 2018; 7(2):233-248.
PMID: 30027457
PMC: 6283785.
DOI: 10.1007/s40120-018-0105-0.
Asymmetric Drug-Induced Parkinsonism and Psychopathology: A Prospective Naturalistic Study in Long-Stay Psychiatric Patients.
Pieters L, Bakker P, van Harten P
Front Psychiatry. 2018; 9:18.
PMID: 29459835
PMC: 5807329.
DOI: 10.3389/fpsyt.2018.00018.
Blink rate is associated with drug-induced parkinsonism in patients with severe mental illness, but does not meet requirements to serve as a clinical test: the Curacao extrapyramidal syndromes study XIII.
Mentzel C, Bakker P, van Os J, Drukker M, Matroos G, Tijssen M
J Negat Results Biomed. 2017; 16(1):15.
PMID: 28841828
PMC: 6888915.
DOI: 10.1186/s12952-017-0079-y.
Risk Factors for Tremor in a Population of Patients with Severe Mental Illness: An 18-year Prospective Study in a Geographically Representative Sample (The Curacao Extrapyramidal Syndromes Study XI).
Mentzel C, Bakker P, van Os J, Drukker M, van den Oever M, Matroos G
Tremor Other Hyperkinet Mov (N Y). 2017; 7:468.
PMID: 28690921
PMC: 5498800.
DOI: 10.7916/D8GH9QHC.